Mandate

Vinge advises Internationella Engelska Skolan in connection with listing on Nasdaq Stockholm

September 29, 2016

Vinge has advised Internationella Engelska Skolan i Sverige Holding s II AB (publ) (“IES”) in connection with its listing on Nasdaq Stockholm.

The prospectus was published on 19 September 2016 and the first day of trading on Nasdaq was 29 September 2016. The offer price was SEK 52 per share, which corresponded to a market value for the total number of shares in the company of MSEK 2 083. The total value of the offering amounted to MSEK 599 provided an overallotment option was exercised in its entirety. No shares or other securities were issued by IES in connection with the offering.

IES is one of the leading independent actors within education in Sweden with approximately 21 400 pupils distributed among 30 schools as of the start of school for the academic year 2016/2017 and with pupils from 50 per cent of the country’s municipalities. IES conducts school operations from grade 1 of the nine-year compulsory school up to and including grade 3 at upper secondary school. The main part of the operations is conducted for students in grades 4 to 9, which is designated internationally as middle school. Within the nine-year compulsory school segment, IES is the leading education provider in terms of the number of pupils and runs 9 of the 10 largest independent schools in Sweden.

Vinge’s team primarily consisted of partner Jesper Schönbeck together with associates Jo-Anna Nordström, Nils Fredrik Dehlin, André Isacson and Ludvig Belke. Partner Louise Brorson Salomonson and associate Helena Håkansson advised on financing issues and associate Henrik Wastersson advised on tax issues. 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025